Library Subscription: Guest
Critical Reviews™ in Immunology

Published 6 issues per year

ISSN Print: 1040-8401

ISSN Online: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Regulatory Roles of the Tumor Necrosis Factor Receptor BCMA

Volume 32, Issue 4, 2012, pp. 287-305
DOI: 10.1615/CritRevImmunol.v32.i4.10
Get accessGet access

ABSTRACT

B cell maturation antigen (BCMA) is a tumor necrosis family receptor (TNFR) member that is predominantly expressed on terminally differentiated B cells and, upon binding to its ligands B cell activator of the TNF family (BAFF) and a proliferation inducing ligand (APRIL), delivers pro-survival cell signals. Thus, BCMA is mostly known for its functional activity in mediating the survival of plasma cells that maintain long-term humoral immunity. The expression of BCMA has also been linked to a number of cancers, autoimmune disorders, and infectious diseases that suggest additional roles for BCMA activity. Despite recent advances in our understanding of the roles for the related TNFR members BAFF-R and transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI), the signaling pathway used by BCMA for mediating plasma cell survival as well as its putative function in certain disease states are not well understood. By examining the expression, regulation, and signaling targets of BCMA, we may gain further insight into this receptor and how it operates within cells in both health and disease. This information is important for identifying new therapeutic targets that may be relevant in treating diseases that involve the BAFF/APRIL cytokine network.

CITED BY
  1. Luu Van Phi, Hevezi Peter, Vences-Catalan Felipe, Maravillas-Montero José Luis, White Clayton Alexander, Casali Paolo, Llorente Luis, Jakez-Ocampo Juan, Lima Guadalupe, Vilches-Cisneros Natalia, Flores-Gutiérrez Juan Pablo, Santos-Argumedo Leopoldo, Zlotnik Albert, TSPAN33 is a novel marker of activated and malignant B cells, Clinical Immunology, 149, 3, 2013. Crossref

  2. El-Komy Mohamed H.M., Tawfik Shereen O., Shaker Olfat G., Expression of the B-cell maturation antigen and a proliferation-inducing ligand in psoriatic plaques, Journal of the Egyptian Womenʼs Dermatologic Society, 11, 1, 2014. Crossref

  3. Mueller Antje, Brieske Christoph, Schinke Susanne, Csernok Elena, Gross Wolfgang L, Hasselbacher Katrin, Voswinkel Jan, Holl-Ulrich Konstanze, Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitis, Arthritis Research & Therapy, 16, 1, 2014. Crossref

  4. Goenka Radhika, Scholz Jean L., Sindhava Vishal J., Cancro Michael P., New roles for the BLyS/BAFF family in antigen-experienced B cell niches, Cytokine & Growth Factor Reviews, 25, 2, 2014. Crossref

  5. Coquery Christine M., Loo William M., Wade Nekeithia S., Bederman Annelise G., Tung Kenneth S., Lewis Janet E., Hess Henry, Erickson Loren D., BAFF Regulates Follicular Helper T Cells and Affects Their Accumulation and Interferon-γ Production in Autoimmunity, Arthritis & Rheumatology, 67, 3, 2015. Crossref

  6. Wei Fang, Xu Shu, Jia Xiaoyi, Sun Xiaojing, Yang Xuezhi, Wei Wei, Chang Yan, BAFF and its receptors involved in the inflammation progress in adjuvant induced arthritis rats, International Immunopharmacology, 31, 2016. Crossref

  7. Wei Fang, Chang Yan, Wei Wei, The role of BAFF in the progression of rheumatoid arthritis, Cytokine, 76, 2, 2015. Crossref

  8. Saxena R., Bjonnes A.C., Georgopoulos N.A., Koika V., Panidis D., Welt C.K., Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume, Human Reproduction, 30, 7, 2015. Crossref

  9. Jasek M., Wagner M., Sobczynski M., Wolowiec D., Kuliczkowski K., Woszczyk D., Kielbinski M., Kusnierczyk P., Frydecka I., Karabon L., Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL - a preliminary study on a Polish population, Tissue Antigens, 86, 4, 2015. Crossref

  10. Matsuda Yoshiko, Haneda Masataka, Kadomatsu Kenji, Kobayashi Takaaki, A proliferation-inducing ligand sustains the proliferation of human naïve (CD27−) B cells and mediates their differentiation into long-lived plasma cells in vitro via transmembrane activator and calcium modulator and cyclophilin ligand interactor and B-cell mature antigen, Cellular Immunology, 295, 2, 2015. Crossref

  11. Higdon Lauren E., Scholz Jean L., Cancro Michael P., BAFF and B Cell Development, Homeostasis, and Selection, in Encyclopedia of Immunobiology, 2016. Crossref

  12. Ehrenstein Michael R., Wing Charlotte, The BAFFling effects of rituximab in lupus: danger ahead?, Nature Reviews Rheumatology, 12, 6, 2016. Crossref

  13. Hou Weihua, Meng Xianchao, Wang Yuxiong, Mo Wei, Wu Yi, Yu Min, Characterization and high-yield production of non-N-glycosylated recombinant human BCMA-Fc inPichia pastoris, Engineering in Life Sciences, 17, 2, 2017. Crossref

  14. Zhang Feng, Song Shan-shan, Shu Jin-ling, Li Ying, Wu Yu-jing, Wang Qing-tong, Chen Jing-yu, Chang Yan, Wu Hua-xun, Zhang Ling-ling, Wei Wei, BAFF upregulates CD28/B7 and CD40/CD154 expression and promotes mouse T and B cell interaction in vitro via BAFF receptor, Acta Pharmacologica Sinica, 37, 8, 2016. Crossref

  15. Mosley Yung-Yi C., HogenEsch Harm, Selection of a suitable reference gene for quantitative gene expression in mouse lymph nodes after vaccination, BMC Research Notes, 10, 1, 2017. Crossref

  16. Matsuda Yoshiko, Imamura Ryoichi, Takahara Shiro, Evaluation of Antigen-Specific IgM and IgG Production during an In Vitro Peripheral Blood Mononuclear Cell Culture Assay, Frontiers in Immunology, 8, 2017. Crossref

  17. Lang Julie, Zhang Bicheng, Kelly Margot, Peterson Jacob N., Barbee Jacob, Freed Brian M., Di Santo James P., Matsuda Jennifer L., Torres Raul M., Pelanda Roberta, Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice, Blood Advances, 1, 27, 2017. Crossref

  18. Myles Arpita, Scholz Jean L., Cancro Michael P., BAFF/BLyS Family, in Encyclopedia of Signaling Molecules, 2018. Crossref

  19. Ansari Mahbubeh, Yazdani Reza, Sherkat Roya, Homayouni Vida, Ganjalikhani-Hakemi Mazdak, Rezaei Abbas, Decreased Expression of B cell Maturation Antigen in Patients with Common Variable Immunodeficiency, Pediatric Allergy, Immunology, and Pulmonology, 30, 1, 2017. Crossref

  20. Myles Arpita, Scholz Jean L., Cancro Michael P., BAFF/BLyS Family, in Encyclopedia of Signaling Molecules, 2016. Crossref

  21. Bishop Gail A., Stunz Laura L., Hostager Bruce S., TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation, Frontiers in Immunology, 9, 2018. Crossref

  22. Schmidts Andrea, Ormhøj Maria, Choi Bryan D., Taylor Allison O., Bouffard Amanda A., Scarfò Irene, Larson Rebecca C., Frigault Matthew J., Gallagher Kathleen, Castano Ana P., Riley Lauren S., Cabral Maria L., Boroughs Angela C., Velasco Cárdenas Rubí M.-H., Schamel Wolfgang, Zhou Jing, Mackay Sean, Tai Yu-Tzu, Anderson Kenneth C., Maus Marcela V., Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma, Blood Advances, 3, 21, 2019. Crossref

  23. Trigos Anna S, Pearson Richard B, Papenfuss Anthony T, Goode David L, Somatic mutations in early metazoan genes disrupt regulatory links between unicellular and multicellular genes in cancer, eLife, 8, 2019. Crossref

  24. Jackson Shaun W, Davidson Anne, BAFF inhibition in SLE—Is tolerance restored?, Immunological Reviews, 292, 1, 2019. Crossref

  25. Dawood Lamees M., Elshabacy Fatemah A., Ghanem Heba B., B-Cell Activating Factor (BAFF) and Its Receptors in Systemic Lupus Erythematosus, Rheumatoid Arthritis, SSRN Electronic Journal, 2018. Crossref

  26. Maglione Paul J., Ko Huaibin M., Tokuyama Minami, Gyimesi Gavin, Soof Camilia, Li Mingjie, Sanchez Eric, Chen Haiming, Radigan Lin, Berenson James, Cunningham-Rundles Charlotte, Serum B-Cell Maturation Antigen (BCMA) Levels Differentiate Primary Antibody Deficiencies, The Journal of Allergy and Clinical Immunology: In Practice, 8, 1, 2020. Crossref

  27. Bae Jooeun, Parayath Neha, Ma Wenxue, Amiji Mansoor, Munshi Nikhil, Anderson Kenneth C., BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications, Leukemia, 34, 1, 2020. Crossref

  28. Bae Jooeun, Samur Mehmet, Richardson Paul, Munshi Nikhil C., Anderson Kenneth C., Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy, Leukemia, 33, 9, 2019. Crossref

  29. Nguyen Doan C., Joyner Chester J., Sanz Iñaki, Lee F. Eun-Hyung, Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells, Frontiers in Immunology, 10, 2019. Crossref

  30. Giuliani Nicola, Accardi Fabrizio, Marchica Valentina, Dalla Palma Benedetta, Storti Paola, Toscani Denise, Vicario Emanuela, Malavasi Fabio, Novel targets for the treatment of relapsing multiple myeloma, Expert Review of Hematology, 12, 7, 2019. Crossref

  31. Karpinski Pawel, Rossowska Joanna, Sasiadek Maria Malgorzata, Immunological landscape of consensus clusters in colorectal cancer, Oncotarget, 8, 62, 2017. Crossref

  32. Dong Zhaocheng, Liu Zhiyuan, Dai Haoran, Liu Wenbin, Feng Zhendong, Zhao Qihan, Gao Yu, Liu Fei, Zhang Na, Dong Xuan, Zhou Xiaoshan, Du Jieli, Huang Guangrui, Tian Xuefei, Liu Baoli, Asmann Charles Elias, The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy, Journal of Immunology Research, 2020, 2020. Crossref

  33. Iannazzo Daniela, Ettari Roberta, Giofrè Salvatore, Eid Ali H., Bitto Alessandra, Recent Advances in Nanotherapeutics for Multiple Myeloma, Cancers, 12, 11, 2020. Crossref

  34. Shah Nina, Aiello Jack, Avigan David E, Berdeja Jesus G, Borrello Ivan M, Chari Ajai, Cohen Adam D, Ganapathi Karthik, Gray Lissa, Green Damian, Krishnan Amrita, Lin Yi, Manasanch Elisabet, Munshi Nikhil C, Nooka Ajay K, Rapoport Aaron P, Smith Eric L, Vij Ravi, Dhodapkar Madhav, The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma, Journal for ImmunoTherapy of Cancer, 8, 2, 2020. Crossref

  35. Danielewicz Hanna, Gurgul Artur, Dębińska Anna, Myszczyszyn Grzegorz, Szmatoła Tomasz, Myszkal Anna, Jasielczuk Igor, Drabik-Chamerska Anna, Hirnle Lidia, Boznański Andrzej, Maternal atopy and offspring epigenome-wide methylation signature, Epigenetics, 16, 6, 2021. Crossref

  36. Leow Christopher Chang-Yew, Low Michael Sze Yuan, Targeted Therapies for Multiple Myeloma, Journal of Personalized Medicine, 11, 5, 2021. Crossref

  37. Yu Bo, Jiang Tianbo, Liu Delong, BCMA-targeted immunotherapy for multiple myeloma, Journal of Hematology & Oncology, 13, 1, 2020. Crossref

  38. Matson Erik M., Abyazi Miranda L., Bell Kayla A., Hayes Kevin M., Maglione Paul J., B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease, Frontiers in Immunology, 11, 2021. Crossref

  39. Allegra Alessandro, Gioacchino Mario Di, Tonacci Alessandro, Petrarca Claudia, Gangemi Sebastiano, Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective, Nanomaterials, 11, 11, 2021. Crossref

  40. Hu Shanshan, Wang Rui, Zhang Mei, Liu Kangkang, Tao Juan, Tai Yu, Zhou Weijie, Wang Qingtong, Wei Wei, BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway, Biomedicine & Pharmacotherapy, 114, 2019. Crossref

  41. Mikkilineni Lekha, Kochenderfer James N., CAR T cell therapies for patients with multiple myeloma, Nature Reviews Clinical Oncology, 18, 2, 2021. Crossref

  42. Feng Deming, Sun Jian, Overview of anti‐BCMA CAR‐T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma, Scandinavian Journal of Immunology, 92, 2, 2020. Crossref

  43. Hosny Mashhour, Verkleij Christie P. M., van der Schans Jort, Frerichs Kristine A., Mutis Tuna, Zweegman Sonja, van de Donk Niels W. C. J., Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma, Journal of Clinical Medicine, 10, 19, 2021. Crossref

  44. Hammood Manar, Craig Andrew, Leyton Jeffrey, Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)—A Necessity for Future ADC Research and Development, Pharmaceuticals, 14, 7, 2021. Crossref

  45. Boothby Mark R., Hodges Emily, Thomas James W., Molecular regulation of peripheral B cells and their progeny in immunity, Genes & Development, 33, 1-2, 2019. Crossref

  46. Tremblay Patricia G., Fortin Chloé, Sirard Marc-André, Gene cascade analysis in human granulosa tumor cells (KGN) following exposure to high levels of free fatty acids and insulin, Journal of Ovarian Research, 14, 1, 2021. Crossref

  47. Tian Zheng, Liu Ming, Zhang Ya, Wang Xin, Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies, Journal of Hematology & Oncology, 14, 1, 2021. Crossref

  48. Carrillo-Ballesteros F. J., Palafox-Sánchez C. A., Franco-Topete R. A., Muñoz-Valle J. F., Orozco-Barocio G., Martínez-Bonilla G. E., Gómez-López C. E., Marín-Rosales M., López-Villalobos E. F., Luquin S., Castañeda-Chávez A., Oregon-Romero Edith, Expression of BAFF and BAFF receptors in primary Sjögren’s syndrome patients with ectopic germinal center-like structures, Clinical and Experimental Medicine, 20, 4, 2020. Crossref

  49. Simón Rocío, Díaz-Rosales Patricia, Tafalla Carolina, The Ancient Cytokine BAFF- and APRIL-like Molecule Regulates the Functionality of Teleost IgM+ B Cells Similarly to BAFF and APRIL, The Journal of Immunology, 206, 8, 2021. Crossref

  50. Shin Charles, Kim Sung Soo, Jo Yong Hwa, Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications, Molecular Therapy - Oncolytics, 22, 2021. Crossref

  51. Swan Dawn, Routledge David, Harrison Simon, The evolving status of immunotherapies in multiple myeloma: the future role of bispecific antibodies, British Journal of Haematology, 196, 3, 2022. Crossref

  52. Chen Zhaochun, Diaz Giacomo, Pollicino Teresa, Zhao Huaying, Engle Ronald E., Schuck Peter, Shen Chen-Hsiang, Zamboni Fausto, Long Zhifeng, Kabat Juraj, De Battista Davide, Bock Kevin W., Moore Ian N., Wollenberg Kurt, Soto Cinque, Govindarajan Sugantha, Kwong Peter D., Kleiner David E., Purcell Robert H., Farci Patrizia, Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure, Proceedings of the National Academy of Sciences, 115, 48, 2018. Crossref

  53. Guo Ruiting, Lu Wenyi, Zhang Yi, Cao Xinping, Jin Xin, Zhao Mingfeng, Targeting BCMA to Treat Multiple Myeloma: Updates From the 2021 ASH Annual Meeting, Frontiers in Immunology, 13, 2022. Crossref

  54. Topp Max S., Duell Johannes, Zugmaier Gerhard, Attal Michel, Moreau Philippe, Langer Christian, Krönke Jan, Facon Thierry, Salnikov Alexey V., Lesley Robin, Beutner Karl, Kalabus James, Rasmussen Erik, Riemann Kathrin, Minella Alex C., Munzert Gerd, Einsele Hermann, Anti–B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma, Journal of Clinical Oncology, 38, 8, 2020. Crossref

  55. Quazi Sameer, An Overview of CAR T Cell Mediated B Cell Maturation Antigen Therapy, Clinical Lymphoma Myeloma and Leukemia, 22, 6, 2022. Crossref

  56. Maus Marcela V., June Carl H., Zoom Zoom: Racing CARs for Multiple Myeloma, Clinical Cancer Research, 19, 8, 2013. Crossref

  57. Nobari Shirin Teymouri, Nojadeh Jafar Nouri, Talebi Mehdi, B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages, Journal of Translational Medicine, 20, 1, 2022. Crossref

  58. Lancman Guido, Sastow Dahniel L., Cho Hearn J., Jagannath Sundar, Madduri Deepu, Parekh Samir S., Richard Shambavi, Richter Joshua, Sanchez Larysa, Chari Ajai, Bispecific Antibodies in Multiple Myeloma: Present and Future, Blood Cancer Discovery, 2, 5, 2021. Crossref

  59. Ndacayisaba Libere J., Rappard Kate E., Shishido Stephanie N., Setayesh Sonia M., Tang Guilin, Lin Pei, Matsumoto Nicholas, Hsu Ching-Ju, Nevarez Rafael, Velasco Carmen Ruiz, Naghdloo Amin, Yang Eric, Kelly Kevin, Hicks James, Mason Jeremy, Orlowski Robert Z., Manasanch Elisabet E., Kuhn Peter, Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms, International Journal of Molecular Sciences, 23, 21, 2022. Crossref

Forthcoming Articles

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain